SI-BONE, Inc. (SIBN): Cost of Revenue
$41.05M
Year ended 2025-12-31
$43.73M
Trailing 12 months to 2026-06-30
+37.7%
3-year compound annual growth
+35.8%
5-year compound annual growth
| Period ended | Cost of Revenue | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $41.05M | +17.1% | 2026-02-24, From 2025-01-01 |
| 2024-12-31 | $35.06M | +19.0% | 2026-02-24, From 2024-01-01 |
| 2023-12-31 | $29.47M | +87.6% | 2026-02-24, From 2023-01-01 |
| 2022-12-31 | $15.71M | +50.6% | 2025-02-25, From 2022-01-01 |
| 2021-12-31 | $10.43M | +17.1% | 2023-03-02, From 2021-01-01 |
| 2020-12-31 | $8.90M | +31.1% | 2022-03-01, From 2020-01-01 |
| 2019-12-31 | $6.79M | +40.5% | 2021-03-10, From 2019-01-01 |
| 2018-12-31 | $4.83M | -5.5% | 2020-03-11, From 2018-01-01 |
| 2017-12-31 | $5.11M | n/a | 2019-03-14, From 2017-01-01 |
Cost of Revenue at similar companies
| Company | Year ended | Cost of Revenue | Change YoY |
|---|---|---|---|
| SI-BONE, Inc. (SIBN) | 2025-12-31 | $41.05M | +17.1% |
| Treace Medical Concepts, Inc. (TMCI) | 2025-12-31 | $42.94M | +4.5% |
| Heartflow, Inc. (HTFL) | 2025-12-31 | $40.84M | +30.2% |
| Orthopediatrics Corp (KIDS) | 2025-12-31 | $63.69M | +13.5% |
| Lemaitre Vascular Inc (LMAT) | 2025-12-31 | $71.06M | +3.0% |
| Neuronetics, Inc. (STIM) | 2025-12-31 | $76.85M | +270.7% |
| InfuSystem Holdings, Inc (INFU) | 2025-12-31 | $63.14M | -2.0% |
| SkinHealth Systems Inc. (SKIN) | 2025-12-31 | $104.43M | -31.3% |
| Xtant Medical Holdings, Inc. (XTNT) | 2025-12-31 | $49.65M | +1.2% |
Compare SIBN, TMCI, HTFL, KIDS side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗